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Cardiometabolic diseases are some of the leading causes of death in the United States 
with African Americans being at greater risk of mortality from these diseases. Physical inactivity 
has been shown to be a risk factor for cardiometabolic diseases. Increased levels of non-exercise 
physical activity has been shown to influence cardiometabolic risk factors. PURPOSE: The 
purpose of the present study is to examine the effects of exercise intensity on non-exercise 
physical activity. As well as examine the effects of increased levels of non-exercise physical 
activity on cardiometabolic risk factors. METHODS: An all African American sample was 
recruited and randomized into three groups: control (n=15), moderate-intensity exercise (n=12), 
high-intensity exercise (n=12). The two exercise groups participated in 24 weeks of aerobic 
exercise with each group exercising at their assigned intensity. The moderate-intensity group 
exercised at a HR associated with 50% of their VO2max and the high-intensity group exercised at 
a HR associated with 75% of their VO2max. Non-exercise physical activity was assessed using a 
Fitbit Flex that was continuously wore by all participants except during exercise sessions. An 
analysis of variance (ANOVA) was used to determine if there were between group differences in 
steps, light-intensity physical activity, and MVPA. To analyze change in steps, light-intensity 
physical activity, and MVPA and other cardiometabolic risk factors, a pearson’s correlation was 
 
 
utilized RESULTS: There were no significant changes in non-exercise physical activity 
variables and cardiometabolic risk factors between groups but the change in VO2peak was 
significantly higher in the high-intensity group compared to the control group (p≤0.05). For the 
moderate-intensity group, change in fat mass and change in time in vigorous-intensity (r=-0.61 
p>.05) and MVPA (r=-0.58 p<.05). For the high-intensity group, change in triglycerides and 
time in vigorous-intensity (r=0.61 p<.05) and change in glucose and steps (r=0.58 p<.05) and 
time in light-intensity (r=0.65 p<0.05) for high intensity. After splitting the data into tertiles 
based on change in steps, there was significant between group differences change in 
steps(p≤0.001), time in light-intensity(p≤0.001), time in moderate-intensity(p≤0.01), time in 
vigorous-intensity(p≤0.01), time in MVPA(p≤0.01). As well the between group change in weight 
(p=0.08) and BMI (p=0.083) approach significant. CONCLUSION: In the present study, no 
compensatory effect of starting a moderate- or high-intensity aerobic exercise was seen on non-
exercise physical activity. Additionally, there were benefits to cardiometabolic risk factors with 
increased levels of non-exercise physical activity, specifically fat mass. Further examination of 
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Chapter I: Introduction 
In 2016, cardiovascular disease and type 2 diabetes were the number one and number 
seven causes of deaths in the United States.1  Many risk factors have been shown to increase the 
risk of cardiovascular mortality including hyperglycemia, hypertension, dyslipidemia, obesity, 
and a sedentary lifestyle.2,3  Studies have shown that there is a dose-response relationship 
between physical activity and cardiovascular and all-cause mortality.4,5  While increasing 
moderate- to vigorous-physical activity (MVPA) has been shown to improve cardiovascular 
mortality, recently sedentary behavior has been identified as a risk factor for cardiovascular 
disease.6-9  
Independent of MVPA, high levels of sedentary behavior (e.g. sitting time) has been 
shown to increase cardiovascular mortality.6-9  Overall our sitting time has been increasing in the 
United States.10  For example, since 1950 the average United States household has increased its 
television watching by 36 minutes every 10 years.11  This increased sitting time is associated 
with higher levels of several cardiometabolic risk factors such as obesity, dyslipidemia, 
hyperglycemia, and hypertension compared to low levels of sitting time.8,12  Cross-sectional 
studies have shown that decreasing sitting time decreases these cardiometabolic risk factors.13-15  
This supports the idea that sedentary time, independent of MVPA, should be considered an 
independent risk factor for cardiometabolic disease. 
Replacing sitting time with light-intensity physical activity has been examined as a 
potential intervention to decrease potential cardiometabolic risk factors. Epidemiological studies 
have shown that replacing sitting time with light-intensity exercise decreases cardiovascular 
mortality, independent of MVPA.12,16 These findings suggest that by increasing light-intensity 
physical activity could have an effect on cardiometabolic risk factors, independent of MVPA.
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With accumulating evidence that displacing sitting time with light-intensity physical 
activity, independent of MVPA, there is potential that non-exercise physical activity has an 
effect on cardiometabolic risk factors. Non-exercise physical activity is defined as any physical 
activity performed outside of structured exercise.17 Exercise interventions looking at the effects 
of non-exercise physical activity have shown that increased levels of non-exercise physical 
activity, independent of MVPA, improved cardiometabolic risk factors such as body composition 
and glucose tolerance.2,18,19  Though the exact mechanism is still unclear, more research is 
needed to understand the effects of non-exercise physical activity on cardiometabolic risk 
factors.  
The purpose of this current study is to examine the effects of exercise intensity on non-
exercise physical activity. The study will examine at the effects a moderate-intensity and 
vigorous-intensity exercise intervention has on participant’s non-exercise physical activity. We 
hypothesize that there will be no change in non-exercise physical activity between different 
exercise intensity groups. Based on current literature, there is no evidence that there would be 
any differences between exercise intensity groups.20 We also hypothesize that participants with 
higher levels of non-exercise physical activity will have greater changes in body composition, 
total cholesterol levels, waist circumference, and insulin sensitivity than those with lower levels 
of non-exercise physical activity. This hypothesis is based on current literature which shows that 
non-exercise physical activity, independent of MVPA, improves cardiometabolic risk factors.2,18-
20  Through the higher levels of non-exercise physical activity there is potential for higher levels 
of energy expenditure and increased lipoprotein lipase regulation.21-23  This study will help 
increase the knowledge regarding the impact of exercise intensity has on non-exercise physical 




 Limitations of the current study are the use of African Americans only, the use of obese 
participants, and the use of either moderate-intensity or vigorous-intensity aerobic exercise. 
Using only obese African American participants, limits the generalizability to other racial groups 
and weight populations. The generalizability will be limited to only moderate-intensity or 
vigorous-intensity aerobic exercise and not to other exercise intensities or modalities.  


















Chapter II: Literature Review 
Physical Activity and Mortality 
 Cardiovascular disease and type 2 diabetes are two of the leading causes of mortality in 
the United States. Some major cardiometabolic risk factors include hyperglycemia, hypertension, 
dyslipidemia, obesity, and a sedentary lifestyle.2,3 In particular, MVPA has been shown in a 
multitude of studies to play a key role in preventing cardiovascular disease and diabetes.2-
5,10,17,24,25  The current recommendations from the American College of Sports Medicine (ACSM) 
suggests that adults should participate in a minimum of 30 minutes of moderate-intensity 
physical activity 5 days per week or 20 minutes of vigorous-intensity physical activity 3 days per 
week to lower their risk of cardiometabolic disease.3 This recommendation is supported by 
epidemiological evidence showing an inverse relationship between high physical activity levels 
and all cause/cardiovascular mortality.4,5,25   In general many of these studies support a dose 
response relationship between level of physical activity and mortality risk.4,5  Adequate levels of 
physical activity has been shown to reduce the risk of cardiovascular mortality by 20%-50%.5,25 
For example, in the Nurses’ Health Study, Rockhill et al.5  examined the association between 
physical activity and mortality. Levels of physical activity were assessed by questionnaire and 
were reevaluated every 2 to 4 years over a 20 year period.5  After excluding women with a 
history of cardiovascular disease or cancer at baseline, 80348 women were included in the 
analysis.5 The results of the study suggest that levels of physical activity were inversely 
associated with all-cause mortality risk (p<.001).5 Also, results showed that the dose-response 
relationship between level of physical activity and mortality was significant (p<.0001).5  Another 
finding was that participants who had less than 1 hour per week of physical activity had a 20-
31% increase in risk of cardiovascular mortality compared to those that participated in more than
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1 hour per week of physical activity (Ptrend>.001).5  A moderate mortality risk reduction of 20-
25% was shown among women walking less than 1 hour per week with addition of more than 1 
hour per week of vigorous activity.5   
 Similarly, in the Harvard Alumni Study by Lee et al.4  examined the independent 
association of physical activity and all-cause mortality. Physical activity level (n=17321 males)  
was assessed using a questionnaire and participants were followed over a 26 year period.4  The 
data showed a graded inverse relationship between total physical activity and mortality 
(p<.001).4  Men who expended more than 6300 kJ per week in vigorous physical activity had 13-
25% lowers risk of all-cause mortality compared to those who expended less than 6300 kJ per 
week.4  The difference in mortality risk is approximately at the same magnitude as being 20% or 
more overweight and being at an ideal weight.4  
 While the previous studies evaluated all-cause mortality, high levels of physical activity 
have been shown to reduce risk of cardiovascular mortality compared to low levels of physical 
activity.5,25  A limitation of the previous studies is that they used only questionnaires to assess 
physical activity levels instead of an objective measure like accelerometer. To address this 
limitation, Evenson et al.25 used accelerometer-assessed physical activity level to determine if 
there was any difference between the self-reported questionnaires and the objective measures. 
The data that was used in this study was obtained from NHANES (2003-2006).25 An Actigraph 
AM7164 and questionnaires were used to assess MVPA.25 Participants (n=3809) had to wear the 
accelerometer for a minimum of 3 days for at least 8 hours/day in order to be included.25 The 
results show that the highest level quartile of MVPA have a 50% less risk of cardiovascular 
mortality than those in the lowest quartile (Ptrend=0.001).25
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The above data suggest that MVPA in an independent risk factor for all-cause and 
cardiovascular disease mortality. Particularly the pursuit of physical activity within the moderate 
to vigorous range independent of major other independent risk factors such as smoking, 
hypertension, race and obesity.5,25  
 
Sedentary Behavior and Mortality  
While physical activity levels and cardiorespiratory fitness are known risk factors for 
cardiovascular disease, recently the amount of time spent in sedentary time (even in individuals 
meeting PA guidelines) has emerged as a potential risk factor for all-cause and cardiovascular 
mortality.10,17,26  Sedentary behavior is defined as any waking behavior involving little to no 
energy expenditure (1.0-1.5 METs) while in a sitting or reclining position.27  It has been found 
that people spend as much of 50%-60% of their waking hours in sedentary behaviors.26 Average 
time spent in sedentary behavior has been found to be 7.7 to 9.5 hours per day.26-28    People are 
increasingly spending more time in sedentary behaviors.10 For example, since 1950 the average 
United States household has increased its television watching by 36 minutes every 10 years.11 
The amount of television watching has been shown to be the strongest associated sedentary 
behavior with increased risk of mortality compared to other sedentary behaviors (e.g. sitting in a 
car, bus, at work, and doing other leisure activities).8,9  
Several epidemiological studies have found that sedentary behavior is associated with 
mortality independent of physical activity level.6-9 People who spent7-12 hours per day in 
sedentary time had an increased your risk of cardiovascular mortality by 19%-50% compared to 
those <5 hours per day,  independent of MVPA.6-9 Kim et al.9 examined the association between 
total sitting time, time spent performing specific sitting behaviors (e.g. watching TV, sitting in
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the car/at work), and all-cause/cardiovascular mortality. The study included 61,395 men and 
73,201 women aged 45-75 from the Multiethnic Cohort Study and had a median follow up was 
13.7 years.9 Total sitting time and physical activity were assessed using questionnaires.9 In this 
study, sitting ≥10 hours/day compared to <5 hours/day was associated with an increase of 11% in 
all-cause and 19% in cardiovascular mortality for women but not men, independent of MVPA.9  
However, all leisure time sitting activities were associated with an increased risk in all-cause 
mortality with TV watching being the strongest risk.9   
In another epidemiological study, Matthews et al.8  examined 240,819 adults from the 
NIH-AARP Diet and Health Study, ages 50 to 71 with no reported cancer, cardiovascular 
disease, or respiratory disease at baseline. Participants were followed for 8.5 years.8 Sedentary 
behaviors and MVPA were assessed using questionnaires.8 In this study sedentary behaviors 
included television watching and overall sitting time.8 Sedentary behaviors were positively 
associated with mortality (p<.001) after adjustment for age, sex, education, smoking, diet, race, 
and MVPA.8 Compared those who reported <1 hour of television viewing per day, participants 
who viewed ≥7 hours per day had nearly twice the risk of cardiovascular mortality (HR: 1.8; 
95% CI: 1.5, 2.2).8 High amounts of television viewing, even with high levels of MVPA (>7 
hours per week), was associated with elevated risk of  all-cause (HR: 1.4; 95% CI: 1.2-1.7) and 
cardiovascular mortality (HR: 2.0: 95% CI: 1.3-3.0).8  
Matthews et al.7 conducted another epidemiological study examining the difference 
between physical activity, sedentary behavior, and all-cause mortality. This study used 63,308 
participants enrolled in the Southern Community Cohort Study that were ages 40-79 who did not 
report having heart disease, stroke, cancer, Parkinson’s disease, lupus, and multiple sclerosis at 
enrollment.7 A questionnaire was used to assess physical activity level and sedentary behavior.7 
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Participants were followed over a 6.4 year period.7 The results showed, after adjusting for overall 
physical activity level and other covariates, that spending more time being sedentary (>12 
hours/day vs. <5.76 hours/day) was associated with a 20-25% increase in risk for all-cause 
mortality.7 Men specifically had a strong positive association between being sedentary (>12 
hours/day vs. <5.7 hours/day)  and risk of  cardiovascular mortality (HR:2.1, 95% CI: 1.3, 3.5, 
Ptrend<0.01) independent of MVPA.7  
Katzmarzyk et al.6 also studied sedentary behaviors and risk of mortality using 
participants in the Canada Fitness Survey. Baseline data was collected during household visit 
using a lifestyle questionnaire and physical fitness measures to assess sedentary behavior.6 
Participants (n=7278 males, 9735 females) were followed up for an average of 12 years.6 After 
for adjusting for multiple covariates (age, smoking, alcohol consumption, physical activity 
readiness, and leisure time physical activity), higher levels daily sitting time was associated 
increased risk of cardiovascular (Ptrend<0.0001) and all-cause (Ptrend<0.0001) mortality.6 
Katzmarzyk et al. also observed a dose-response relationship between sitting time and mortality 
rates that were similar between those that were inactive (Ptrend<0.0001) and active (Ptrend=0.008).6  
This relationship saw that the highest quintile having a 86% (inactive) and 40% (active) increase 
of mortality compared to the lowest quintile.6   
 
Light-Intensity Physical Activity and Mortality  
Outside of exercise and sedentary behavior, light-intensity physical activity also plays a 
key preventative role independent of MVPA.10,17 After adjusting for MVPA, lower levels of 
light-intensity physical activity have been associated with a 23% increase in all-cause 
mortality.16 Epidemiological studies have also found that replacing sedentary behavior with 
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light-intensity physical activity can reduce risk of all-cause and cardiovascular mortality 23% 
and 24% respectively.12,16  
Matthews et al.16 examined the all-cause mortality dose-response for sedentary time, 
light-intensity physical activity, and MVPA. Accelerometer data (ActiGraph AM-7164) was 
used to assess light-intensity physical activity, sedentary time, and MVPA.16 Data was obtained 
from NHANES and participants were followed up during a 6.6 year follow-up period.16 Light-
intensity physical activity was defined as an activity count of 100-760 or <3 METs.16 Sedentary 
time was defined as an activity count of <100.16  This study showed that those who did 5 hours 
per day of light-intensity physical activity had a 23% lower risk of mortality (HR: 0.77; 95% CI: 
0.6-1.0) than those who only 3 hours per day of light-intensity physical activity after adjusting 
for MVPA.16 Also, those who spend 10 hours per day in sedentary behaviors had a 29% greater 
risk of mortality (HR: 1.29; 95% CI: 1.1-1.5) than those who spent 6 hours per day sedentary 
behaviors.16 A major finding of this study was that in less active individuals replacing 1 hour of 
sedentary with either light-intensity physical activity or MVPA was associated with an 18% and 
42% lower mortality, respectively.16  
Another epidemiological study by Dohrn et al.12  investigated the effect of replacing 
sedentary time with light-intensity physical activity on cardiovascular mortality. Participants 
(n=851) were from the Sweden Attitude Behavior and Change study, wore an Actigraph 7164 
accelerometer for at least one day (>10 hours of wear time).12 Light-intensity physical activity 
was defined as 100-2019 counts/minute.12 The study showed that replacing 30 minutes/day of 
sedentary time with light-intensity physical activity lowered risk of cardiovascular mortality by 
24% (HR:0.96; 95% CI: 0.93-0.99).12 This finding suggests that increasing light-intensity 
physical activity, independent of MVPA, could have an effect on cardiometabolic risk factors.12
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Physical Activity and Cardiometabolic Risk Factors 
 In support of the notion that high sedentary time and low light-intensity physical activity 
may represent as an independent risk factor for cardiometabolic disease, several researchers have 
evaluated cross-sectional studies on cardiometabolic risk factors. These studies have shown that 
higher levels light-intensity physical activity, independent of MVPA, are associated with lower 
odds of elevated waist circumference13, elevated metabolic syndrome score13, lower HDL 
cholesterol15, elevated triglycerides15, and risk of diabetes.14 Healy et al.13 examined the 
associations of objectively measured sedentary time and physical activity through accelerometry 
with metabolic risk factors in adults without known diabetes from the AusDiab study. 
Participants (n=169) were given a uniaxial accelerometer (ActiGraph 7164) to measure sedentary 
and physical activity levels during waking hours for 7 consecutive days.13 Light-intensity activity 
was defined as activity counts between 100-1951 per minute.13 After adjusting for confounding 
factors (e.g. age, sex, employment status, alcohol intake, income, education, smoking status, diet 
quality, and family history of diabetes), there was significant independent association of 
sedentary time, light-intensity time, and mean activity intensity with waist circumference and 
clustered metabolic risk score.13 These results suggests that increased metabolic benefits may be 
obtained by displacing sedentary time with light-intensity activity.13  
 Camhi et al.15 assessed the relationship between moderate non-exercise physical activity 
and cardiometabolic health.  Moderate non-exercise physical activity was assessed using 
accelerometer data from NHANES and defined as 760-2019 counts per minute.15 Participants 
(n=1371) wore the accelerometer (ActiGraph) for seven consecutive days and had a fasted blood 
draw to measure HDL cholesterol triglycerides, and glucose.15 Having a higher moderate non-
exercise physical activity, independent of MVPA, was associated with lower odds of elevated 
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triglycerides (p=0.02), elevated waist circumference (p=0.0006), low HDL cholesterol 
(p<0.0001), metabolic syndrome (p=0.01), and diabetes (p=0.0005).15  Having seen these results, 
it suggests that higher levels of non-exercise physical activity could have an effect on 
cardiometabolic risk factos.15  
 Another study by Healy et al.14 measured the effects of light-intensity physical activity, 
sedentary time, and MVPA on fasting and 2-hour plasma glucose. Actigraph accelerometer data 
from the AusDiab study was used to determine sedentary time, light-intensity physical activity, 
and MVPA.14 An oral glucose tolerance test was evaluated in the participants (n= 67 men, 106 
women) to ascertain 2-hour glucose and fasting plasma glucose.14 Light-intensity physical 
activity was defined as 100-1951 counts per minute.14 When adjusted for age, sex, time 
accelerometer worn, height, waist circumference, accelerometer unit, family history of diabetes, 
alcohol intake, education, income, smoking status, and MVPA, higher light-intensity physical 
activity was associated with significantly lower 2-hour plasma glucose than lower levels of light-
intensity physical activity(p=0.023).14  
 
Changes in Non-exercise Physical Activity Level  
With the accumulation of evidence supporting that non-exercise physical activity level is 
a cardiometabolic risk factor, there is evidence from exercise training studies that non-exercise 
physical activity may have an effect on cardiometabolic risk factors.15 Non-exercise physical 
activity is defined as any physical activity outside of structured exercise sessions.17 There are 
several potential mechanisms why non exercise physical activity may lower cardiometabolic risk 
factors. The most prominent being that there is a cumulative loss of energy expenditure with 
little to none non-exercise physical activity.21,22 By sitting for prolonged periods of time,
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thousands of intermittent muscle contractions are not occurring thus potentially lowering overall 
energy expenditure.21 Another potential mechanism is that lipoprotein lipase regulation is 
decreased with sedentary behavior.23 The thought is without exercise, that muscles are not 
oxidizing fat at the same rate as when they are active.23  A potential causation for these 
mechanism is that when adding MVPA into daily life, people decrease non-exercise physical 
activity and increase sedentary time.17,22  
A study by Rangan et al.20 examined if non-exercise physical activity was affected by 
participating in exercise training. The participants (n=82) were part of the Studies of Targeted 
Risk Reduction Interventions through Defined Exercise (STRRIDE).20 Participants were 
randomized into one of three groups after a four month control period: Aerobic Training (14 
kcal/kg body weight per week at 65%-85% peak VO2), Resistance Training (3 days per week of 
3 sets, 8-12 reps per set of 8 different major muscle groups), and a Combination (full aerobic and 
resistance training protocol).20 Non-exercise physical activity was measured using a tri-axial RT3 
accelerometer worn at the start and end of the control period and during the final week of the 
exercise training protocol.20 The results showed no significant difference in the change in non-
exercise physical activity between the control period and any of the groups.20 These results are 
contrary to the belief that participant will compensate for exercise training by decreasing their 
non-exercise physical activity.21,22  
Similarly, Willis et al.29  examined if there were any compensatory changes in non-
exercise physical activity in response to an aerobic training program. The participants (n=91) 
were obese or overweight sedentary young adults (18-30 years).29   Participants were randomized 
into one of three groups: 400 kcal per session, 600 kcal per session, or control.29  Exercise 
session were completed 5 days per week for 10 months.29  The participants were progressed from
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150 kcal per session at onset to target energy expenditure by the end of month 4.29  Non-exercise 
physical activity was accessed using a uniaxial piezoelectric accelerometer (Actigraph GT1M).29  
The accelerometer was worn over nondominant hip for seven consecutive days at baseline, 3, 5, 
7, and 10 months.29  The accelerometer data for the exercise sessions was removed over the 
duration of that exercise session.29 The results showed there were no significant effects of group, 
time or group-time interaction with non-exercise physical activity (all p>0.05).29  
A few exercise training studies have examined the how non-exercise physical activity 
effects cardiometabolic risk factors.2,18,19 These exercise training studies have shown higher 
levels of non-exercise physical activity leads to larger decreases in waist circumference18, 
weight18, total cholesterol19, and 2-hour oral glucose tolerance.2 Swift et al.18 examine how non-
exercise physical activity affected waist circumference and weight within exercise training 
groups. Participants (n=325) were sedentary postmenopausal women from the Dose Response to 
Exercise in Women (DREW) study and were randomly assigned to one of four groups: control, 4 
kcal/kg per week, 8 kcal/kg per week, and 12 kcal/kg per week.18 Each exercise program was 
conducted for 6 months.18 The participants wore an Accusplit Eagle AE1620 pedometer for the 
entirety of the intervention.18 Non-exercise physical activity was assessed by the pedometers that 
were only worn outside of the exercise training protocol.18 The study showed that higher levels 
of non-exercise physical activity resulted in a greater change in waist circumference (-4.2 cm vs, 
-1.0cm; ptrend<0.001) and weight (-2.0kg vs -1.0kg; ptrend=0.03) than lower levels of non-exercise 
physical activity independent of dose of exercise.18  
 A second study by Di Blasio et al.19 determined if there was difference in non-exercise 
physical activity in participants that were part of an aerobic exercise protocol and the effects it 
had on aerobic training-related adaptations. Participants (n=34 postmenopausal women) were put 
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through a 13-week walking training program (4 days/week 40-50 minutes of moderate 
intensity).19 Non-exercise physical activity was determined by two axis accelerometer 
(SenseWear Pro2) worn over 3 consecutive days.19 During the study two distinct groups 
appeared, one that increased non-exercise physical activity and one that decreased non-exercise 
physical activity.19 Those with an increase in non-exercise physical activity saw a reduced LDL-
cholesterol (F1,17=4.19; P=0.05) and total cholesterol (F1,17=5.89; P=0.027) compared to those 
with a decrease in non-exercise physical activity.19  
Kozey-Keadle et al.2 examined if the combination of exercise training and reducing 
sedentary time resulted in greater changes in health markers than either intervention alone. 
Overweight/obese participants (n=19 males, 39 females) were randomly assigned one of four 12-
week programs: exercise (EX), reducing sedentary time (rST), combination (EX-rST), and 
control (CON).2 Fasting lipids, blood pressure, peak oxygen uptake, BMI, and 2-h oral glucose 
tolerance tests were completed pre- and post-intervention.2 Non-exercise physical activity was 
determined by an activPAL wore at baseline and weeks 3, 6, 9, and 12 of the intervention 
period.2 During the study, rST and EX-rST groups significantly reduced sedentary by 7% (~50 
minutes/day) and 10.3% (70 minutes/day) respectively.2 The EX-rST also significantly improved 
composite insulin-sensitivity index 17.8% (p=<0.05), decreased 2-hour insulin by 33.3% 
(p=<0.01), and decreased insulin area under the curve by -19.4% (p=<0.01).2 Though there was 
no significant changes in the rST group, the findings from the EX-rST group suggest that 
increasing non-exercise physical activity with exercise training may have metabolic benefits that 
are not seen in just exercise alone.2   
Limitations of the current research are that they do not study how exercise intensity 
effects non-exercise physical activity. Also, the exercise interventions were relatively short in 
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length, with only one going longer than 13 weeks.2,18,19 More research should be done to see the 
long-term effects of non-exercise physical activity on cardiometabolic risk factors. There is also, 




 In conclusion, non-exercise physical activity has been shown to have an effect on 
cardiometabolic risk factors independent of MVPA.2,18,19  As a result, non-exercise physical 
activity should be considered a separate cardiometabolic risk factor. Further research is needed to 
define the effects of non-exercise physical activity on other cardiometabolic risk factors. It has 
been shown that different types of exercise can influence non-exercise physical activity however, 
more research needs to be done to see further investigate how non-exercise physical activity 












Chapter 3: Methods 
 The purpose of this present study is to: 1) compare the effects of moderate- and vigorous-
intensity aerobic exercise on non-exercise physical activity and 2) determine if changes in non-
exercise physical activity are associated with changes in other cardiometabolic risk factors. Data 
from this present study was obtained from the High Intensity exercise to Promote Accelerated 
improvements in Cardiorespiratory Fitness (HI-PACE). The primary purpose of the HI-PACE 
study was to determine the effect of exercise intensity on cardiorespiratory fitness and insulin 
sensitivity in obese African Americans. The HI-PACE methodology was reviewed and approved 
by the East Carolina University Institutional Review Board. Written informed consent was 
obtained for each participant prior to study enrollment. 
 
Participants 
 Utilizing flyers, website and newspaper advertisements, and email distribution, 60 
participants were recruited. Inclusion criteria included African American participants, age 40-65 
years, and classified as overweight or obese (30.0-45.0 kg/m2). African American race was 
established by self-report. Exclusion criteria includes diagnosis of type 2 diabetes (blood glucose 
value >125 mg/dL), known cardiovascular diseases, unsafe high resting blood pressure (systolic 
> 180 mmHg; diastolic > 100 mmHg), life threatening conditions, pregnancy or planned 
pregnancies, significant medical conditions/diseases, current engagement in dietary or weight 







  Screening was performed with both a web screen and telephone interview, where a study 
staff member would screen for major aspects of the inclusion and exclusion criteria as well as 
provide additional information about study participation. Eligible participants would then be 
invited to a one-on-one orientation session with the research coordinator to further discuss 
procedures, study design, and associated risks and benefits. Participants interested in enrolling 
provided informed consent. The research coordinator then screen participants for full study 
inclusion/exclusion criteria, collect contact/demographic information, and review prescribed 
medications. Screening measurements taken included: resting blood pressure, BMI, and waist 
circumference. Blood was also drawn and sent to a clinical laboratory for lipid, glucose, insulin 
analyses, and a comprehensive metabolic panel. Baseline physical activity levels was assessed 
using accelerometry measured by a Fitbit Flex (Fitbit Inc., San Francisco, CA) for 7 days. The 








Figure 1. Flow of HI-PACE Study 
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Baseline and Follow-Up Assessment 
Baseline measurements including cardiorespiratory fitness, BMI, DEXA, and waist 
circumference were assessed. These measures were re-assessed at the end of the 24-week 
intervention.  
To determine body mass index (BMI in kg/m2), body weight was measured using a Digi 
Tol calibrated scale (Mettler Toledo, Columbus, OH). Height was measured by utilization of a 
height rod on a balanced scale. Body fat percentage was measured by dual energy x-ray 
absorptiometry (DEXA) (GE Lunar Prodigy Advance, Fairfield, CT). Participants were asked to 
remove all jewelry and shoes, positioned properly on the DEXA machine, and instructed to lie 
motionless on the DEXA machine until scan completion. Waist circumference was measured at 
the natural waist (inferior border of the rib cage, superior aspect of the iliac crest) via a Gulick 
tape measure. 
 A blood sample was drawn with the participant in a fasted state at baseline and follow-up. 
A total of 21 mL of blood was drawn by the study nurse and was immediately sent to a clinical 
laboratory (LabCorp Inc.) for a complete metabolic panel, lipid panel, insulin level, and blood 
chemistries.  
For the present study non-exercise physical activity is defined as any physical activity 
done outside of the prescribed exercise intervention. Non-exercise physical activity data was 
monitored in all groups using a Fitbit Flex activity tracker throughout the 24-week intervention 
period. Each group was blinded to the number of steps accrued via taped cover and instructed to 
not consciously change their non-exercise physical activity levels from baseline. Prior to each 
exercise session, the Fitbit device was removed from the participant and uploaded to the Fitbit 
software. This is done in order to not mix exercise and non-exercise physical activity data. 
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Participants in the non-exercise control group would sync their data at home using the Fitbit 
software and be monitored by study staff to assure compliance. Surveys were emailed 3 times 
per week to all participants to inquire about Fitbit wear. This process helped to ensure consistent 
daily wearing of the device and to determine if the participant did not wear the Fitbit for 
extended periods of time – which was designated as invalid data (e.g. >4 hours of non-wear, 
<1000 steps/day).  
 Study staff used a database program (Fitabase, Small Steps Labs, San Diego, CA) to 
centralize all non-exercise physical activity data, inclusive of total daily steps, minutes of light, 
and moderate and vigorous physical activity
Study Procedures 
 Participants were randomized into either the moderate intensity (n=12), high intensity 
(n=12), or non-exercise control group (n=15) for a period of 24 weeks. Participants, who were 
randomized into one of the exercise groups, engaged in supervised exercise 3-4 days/week on a 
treadmill to maintain control of energy expenditure. 
 The moderate-intensity group exercised at a heart rate associated with 50% , while the 
high-intensity group exercised at a heart rate associated with 75% VO2max. Both groups 
accumulated 600 MET-minutes/week which corresponds with current PA guidelines (500-1,000 
MET-minutes/week). Both groups exercised at 300 MET-minutes during week 1. Each week, the 
volume of exercise was increased by 50 MET-minutes until the 600 MET-minute level was 
achieved by week 7. MET-minutes were calculated via ACSM equations based on treadmill 
speed and grade, and participant weight. 
At the first session of each week the participant’s weight was taken. Also, a medication 
check was given to the participant to determine if there were any changes in medication usage.
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During the medication check the participant was also asked if they are participated in any 
other exercise or diet program, if there was a deliberate change in their non-exercise physical 
activity, and if they have had any adverse symptoms (dizziness, nausea, chest pain, etc.).
Participant heart rate was continuously monitored by use of Zephyr Bioharness 3 
monitors (Annapolis, MD) to monitor and ensure appropriate exercise intensities for each group. 
Following exercise, heart rate data was downloaded to a computer. The start and end of an 
exercise session was timestamped to determine average heart rate for the entire exercise session.  
 
Statistical Analysis 
 Baseline values for continuous variables were accumulated and reported in means and 
standard deviations. Baseline continuous variables were assessed using a one-way analysis of 
variance (ANOVA). To determine if differences existed for baseline categorical values a chi 
square analysis was conducted. A Pearson’s correlation was ran to determine the relationship 
between baseline steps and demographic factors. Change scores were calculated for all 
dependent variables and the change score for each variable was used in all subsequent analyses. 
Participants with any missing data for the cardiometabolic risk factors excluded from analysis. 
Non-exercise physical activity data was imputed for any missing weeks.For the first hypothesis, 
an analysis of variance (ANOVA) was used to determine if there were between group differences 
in steps, light-intensity physical activity, and MVPA. For our second hypothesis to analyze 
change in steps, light-intensity physical activity, and MVPA and other cardiometabolic risk 
factors (body fat percentage, insulin sensitivity, triglycerides, and total cholesterol levels), a 
pearson’s correlation was utilized with an alpha level of <0.05. The data was split into tertiles 
based off change in steps to see if there was a difference in effect on the cardiometabolic risk 
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Chapter IV: Results 
Baseline characteristics are summarized for each study group in Table 1. Each group 
contained the following amounts of participants: control n=15, moderate-intensity n=12, and 
high-intensity n=12. The mean BMI of the study population was 34.47 kg/m2 and the mean VO2 
was 20.00 mL ∙ kg−1 ∙ min−1. There were no significant differences observed between the group 
means for age, sex, weight, BMI, waist circumference, body fat percentage, lipid measurements, 
glucose, insulin, average step count, time in light-intensity, time in moderate-intensity, time in 
vigorous-intensity, and time in MVPA at baseline (Table 2). At baseline steps was correlated 
with BMI (r=-0.36, p≤0.05), fat mass (r=-0.21, p≤0.05), and VO2peak (r=0.51, p≤0.01). 
The mean change scores for each cardiometabolic risk factors and non-exercise physical 
activity for each group are shown in Table 3. There were no significant changes in non-exercise 
physical activity variables and cardiometabolic risk factors between groups but the change in 
VO2peak was significantly higher in the high-intensity group compared to the control group 
(p≤0.05).Further, the change in triglycerides between moderate-intensity and high-intensity 
groups approached significance (p=0.064). 
Looking at the changes in each group individually there were a few correlations between 
non-exercise physical activity and cardiometabolic risk factors (Table 4). For the control group, 
there was a significant correlation between the change in LDL and change in steps (r=-0.67 
p<0.01) and time in light-intensity (r=-0.69 p<.01). For the moderate-intensity, change in fat 
mass and change in time in vigorous-intensity (r=-0.61 p>.05) and MVPA (r=-0.58 p<.05). For 
the high-intensity group, change in triglycerides and time in vigorous-intensity (r=0.61 p<.05) 




To focus specifically on the exercise responses, we evaluated the relationship between 
non-exercise physical activity variables with cardiometabolic risk factors in the participants in 
the exercise intervention groups. For exercisers there was no correlation between the change in 
non-exercise physical activity and the change in cardiometabolic risk factors. 
 The data was split into tertiles based on change in steps to examine the relationship 
between a change in steps and the change in cardiometabolic risk factors. The tertiles were split 
as follows: group 1 Δsteps=-4000 to -1000 (n=12), group 2 Δsteps=-1000 to 250 (n=14), group 3 
Δsteps= 250 to 3500+ (n=13). At baseline (Table 5), there were significant differences in 
steps(p≤0.01), time in light-intensity (p≤0.01), and glucose (p<0.05) (between which groups). In 
the tertile change scores (Table 6) there was significant between group differences change in 
steps(p≤0.001), time in light-intensity(p≤0.001), time in moderate-intensity(p≤0.01), time in 
vigorous-intensity(p≤0.01), time in MVPA(p≤0.01). As well the between group change in weight 












Chapter V: Discussion 
 Multiple epidemiological studies have shown that low levels of sedentary behavior 
decrease cardiovascular and all-cause mortality even in adults who  are meeting the physical 
activity guidelines.6-9 Obese individuals are more likely to not meet physical activity 
recommendations and be more sedentary than leaner individuals.6 Several epidemiological 
studies have shown that replacing sedentary time with light-intensity activity had a reduction in 
cardiometabolic risk factors.13-15 It is theorized though that people who start exercise training 
programs potentially compensate by decreasing non-exercise physical activity.17,22 However, 
there is little data that has compared the impact of two distinct exercise training intensities 
(moderate vs. vigorous). In addition, potential for changes in non-exercise physical activity has 
not been evaluated in obese African Americans (who have elevated CVD risk compared to 
Caucasians). 
 The primary findings of the present study are that in a group of obese African Americans 
were observed no changes in non-exercise physical activity occurred in response to moderate or 
high intensity aerobic exercise training. However, those that did change their non-exercise 
physical activity saw positive changes to their cardiometabolic risk factors, specifically fat mass. 
This suggests that exercise training at moderate or high intensity exercise (in compliance with 
physical activity guidelines) does not result in compensatory changes in non-exercise physical 
activity. In addition, there were some positive changes to cardiometabolic risk factors when non-
exercise physical activity was increased. 
A novel aspect about our study is that we evaluated changes in non-exercise physical 
activity in health disparity population, which have not been reported in a published study to our 
knowledge. In studies of mostly Caucasian samples (or studies where race was not specifically 
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defined20,29) aerobic exercise training did not change non-exercise physical activity.  The HI-
PACE study supports the finding of those studies, as we found no significant change in non-
exercise physical activity during an exercise intervention. Willis et al.29 in a 10 month aerobic 
training study reported that there were no changes in in non-exercise energy expenditure, 
assessed through accelerometerty (ActiGraph) worn at baseline, 3.5, 7, and 10 months, between 
controls, a 400 kcal/session, and a 600 kcal/session group (exercised at 70-80% HRmax), which 
would approximate higher intensity aerobic training Similarly, the authors reported no change in 
time in light-, moderate-, or vigorous-intensity physical activity (p>0.05).29 Furthermore, Rangan 
et al.20 in the STRIDDE AT/RT study observed no change in non-exercise physical activity 
energy expenditure measured via accelerometry between an aerobic training (1.6± 57.0; 14 
kcal/kg body weight per week at 65%-85% peak VO2 [range: moderate to high intensity]), a 
resistance training (-1.8±44.4), and a combination group (19.1±61.7), even though the 
combination group had significantly more exercise energy expenditure. Thus, the present study, 
as other previous studies as well, support that there are no group-based changes in non-exercise 
physical activity variables in response to exercise training.  Therefore, in general terms, 
participation in aerobic exercise training according to PA guidelines does not appear to result in 
major compensatory changes.  
 Although, we did not observe changes in non-exercise physical activity, we performed 
additional analyses to evaluate changes in risk factors across the magnitude of change of non-
exercise PA.  Recently, there has been the suggestion that decreases in non-exercise physical 
activity level with aerobic exercise training could attenuate improvements in cardiometabolic 
risk factors. When it comes to increased levels of non-exercise physical activity, previous studies 
suggest that higher levels of non-exercise physical activity can have an effect on cardiometabolic
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risk factors, such as LDL cholesterol, total cholesterol, weight, waist circumference, and 2-hour 
glucose tolerance.2,18,19 For example, DiBlasio19 et al. saw in a 13 week walking program found 
the higher levels of non-exercise physical activity decreased LDL and total cholesterol As well, 
Swift et al.18 in a 6 month aerobic exercise intervention reported that higher levels of non-
exercise physical activity resulted in a greater change in waist circumference and weight between 
the lowest and highest tertile. These changes were not found in the current study though there 
was a significant correlation between the change in fat mass and change in time in vigorous-
intensity for the moderate-intensity group. A potential reason that the results of this current study 
are not similar to DiBlasio et al. and Swift et al. is that demographics of the current study are 
quite different. Both previous studies used participants that were all postmenopausal women and 
primarily Caucasian. Swift et al. reported their participants were 28% African American. For the 
current study, all participants were African American and 76% female. With the changes seen in 
non-exercise physical activity seen in this present study there is some suggestion that increasing 
non-exercise physical activity could improve cardiometabolic risk factors. 
 A limitation of this current study is the use of commercial grade accelerometers. 
Sushames et al.30 compared the validity and reliability of the Fitbit Flex and Actigraph and the 
results indicated that Fitbit Flex had moderate validity: where the Fitbit flex tended to 
undercount steps and averaged lower levels of MVPA 30 Though the Fitbit Flex could be useful 
in a real-life setting, this may have reduced the accuracy of our measurement of non-exercise 
physical activity. Another limitation of the current study is that this was a randomize clinical trial 
with high level of support to ensure high compliance to aerobic training. Further studies should 
investigate a similar trial in an effectiveness setting. Furthermore, the sample size for the current 
study was low, which lead to spurious correlations in the high intensity group. These correlations
 
27 
were change in glucose and change in steps, change in glucose and change in time in light-
intensity, change in triglycerides and change in time in vigorous-intensity, and change in fitness 
and change in time in vigorous-intensity. This may be due to a couple of outliers in the change in 
glucose and change in steps and time in light intensity pulling the correlation in the opposite 
direction that was excepted. When these outliers were removed from these and reanalyzed the 
direction of the correlation flipped. In a larger sample size, there might be a more discernible 
effect seen.  
The main strength of this study is that wear time of the accelerometer was continuous 
throughout the whole intervention. Previous studies2,19,20,29 only had participants wear 
accelerometers for multiple time points during the intervention. Only 1 study18 to our knowledge 
tracked participant’s non-exercise physical activity continuously18, but that was only through 
pedometers. Another strength of this study was that it was performed in an all African American 
sample. Previous studies were done on unknown racial demographics20,29, low percentage of 
African Americans (28%)18 or postmenopausal women18,19. This is important given the increased 
risk in cardiovascular disease and type 2 diabetes in African Americans. 
 In conclusion, the present study suggests that starting an aerobic training program does 
not change non-exercise physical activity in obese African Americans. Also, that there is 
potential benefit to increase non-exercise physical activity on cardiometabolic risk factors. The 
major public health implications of the present study is that there was no observed compensatory 
effect of starting either a moderate or high intensity exercise program on non-exercise physical 
activity. The results from the present study suggest that clinicians do not need to worry about 
people compensating an exercise program by increasing sedentary time
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Further study should be done investigating the effects on non-exercise physical activity 
on cardiometabolic risk factors within other populations such as those already with chronic 
diseases and older adults. Additionally, future studies should evaluate potential compensatory 
effects of other training modalities (e.g. resistance training, interval training, group fitness 
classes). As well, further studies should investigate larger changes in non-exercise physical 
activity (e.g. purposefully increasing non-exercise physical activity). This will allow insight in to 
whether non-exercise physical activity has any true effect on cardiometabolic risk factors. Within 
this current study and previous studies there seems to between a correlation between increased 
















Table 1: Baseline Characteristics 
 Control (n=15) Moderate Intensity (n=12) High Intensity (n=12) 
Age (yrs.) 49.00 ± 5.66 50.92 ± 7.74 48.38 ± 9.27 
Gender (% female) 76.92 75 76.92 
Weight (kg) 91.53 ± 17.58 98.71 ± 13.07 101.17 ± 18.69 
BMI (kg/m2) 32.61 ± 6.02 35.24 ± 4.87 36.02 ± 5.85 
Waist Circumference (cm) 93.88 ± 11.91 97.80 ± 8.80 103.08 ± 13.51 
Body Fat (kg) 37.09 ± 14.1 42.32 ± 10.47 42.63 ± 10.95 
HDL Cholesterol (mg/dL) 52.33 ± 11.26 54.83 ± 14.59  51.50 ± 16.30 
LDL Cholesterol (mg/dL) 114.13 ± 24.91 113.00 ± 42.74  97.58 ± 21.94 
Total Cholesterol (mg/dL) 186.67 ± 28.05 184.00 ± 42.64 170.33 ± 28.70 
Triglycerides (mg/dL) 100.93 ± 48.50 80.83 ± 24.72 105.67 ± 43.52 
Glucose (mg/dL) 92.67 ± 8.34 93.25 ± 7.59 93.42 ± 8.82 
Insulin (uIU/mL) 13.56 ± 7.68 16.06 ± 10.22 16.33 ± 8.41 
VO2peak (mL ∙ kg−1 ∙ min−1) 21.79 ± 6.23 18.67 ± 4.71 19.10 ± 4.3 
Average Step Count 6445.3 ± 3046.6 6662.9 ± 2181.4 7321.5 ± 3399.5 
Time in Light Intensity (min) 238.88 ± 75.51 231.93 ± 59.16 264.97 ± 61.97 
Time in Moderate Intensity (min) 9.72 ± 14.54 10.14 ± 6.24 10.32 ± 15.95 
Time in Vigorous Intensity (min) 2.09 ± 3.78 4.08 ± 6.24 3.05 ± 4.55 
Time in MVPA (min) 11.81 ± 18.17 13.88 ± 14.27 13.38 ± 20.19 















 Table 2: Change in Intervention Factors 
 Control Moderate Intensity High Intensity 
Δ Weight (kg) 0.88 ± 3.62 0.34 ± 3.42 -0.04 ± 3.21 
Δ BMI (kg/m2) 0.36 ± 1.3 0.14 ± 1.19 0.04 ± 1.25 
Δ Waist Circumference (cm) -1.09 ± 4.31 1.09 ± 5.67 -0.60 ± 2.29 
Δ Body Fat (kg) 0.38 ± 1.96 0.21 ± 3.01 -1.16 ± 3.43 
Δ HDL Cholesterol (mg/dL) -4.13 ± 7.03 -1.33 ± 5.19 0.67 ± 5.97 
Δ LDL Cholesterol (mg/dL) -7.12 ± 14.28 -0.67 ± 15.09 1.53 ±18.66 
Δ Total Cholesterol (mg/dL) -11.00 ± 19.36 -1.00 ± 19.56 -2.25 ± 21.82 
Δ Triglycerides (mg/dL) -8.87 ± 23.89 5.00 ± 19.48+ -16.25 ± 20.89+ 
Δ Glucose (mg/dL) -1.87 ± 8.86 -2.33 ± 6.41 -2.33 ± 8.41 
Δ Insulin (uIU/mL) -2.66 ± 5.50 -2.66 ± 9.59 -2.85 ± 6.84 
Δ VO2peak (mL ∙ kg−1 ∙ min−1) -0.77 ± 2.91* 1.82 ± 2.84 2.68 ± 2.59* 
Average Δ Step Count -35.9 ± 1169.8 -633.4 ± 1236.6 -703.7 ±1753.1 
Δ Time in Light Intensity (min) -17.30 ± 44.43 -16.47 ± 42.08 -30.61 ± 49.02 
Δ Time in Moderate Intensity (min) 0.08 ± 5.05 -4.07 ± 6.30 -1.41 ± 11.63 
Δ Time in Vigorous Intensity (min)+ 1.42 ± 3.40+ -1.35 ± 4.03+ -0.71 ± 2.48 
Δ Time in MVPA (min) 1.53 ± 8.10 -5.09 ± 8.95 -1.95 ± 13.48 
*Change in VO2peak was significant between Control and High-Intensity groups (p=0.008) 
+ Change in triglycerides between Moderate- and High-Intensity (p=0.055) and change in time 















Table 3: Non-Exercise Physical Activity and Cardiometabolic Risk Factor Correlations 
Moderate-Intensity 
Group 
Δ Step Count Δ Time in 
Light Intensity 
(min) 
Δ Time in 
Moderate 
Intensity (min) 
Δ Time in 
Vigorous Intensity 
(min) 
Δ Time in 
MVPA (min) 
Δ Weight (kgs) 0.04 0.15 -0.17 -0.40 -0.38 
Δ BMI (kg/m2) 0.03 0.17 -0.18 -0.42 -0.39 
Δ Waist Circumference 
(cm) 
-0.42 -0.16 -0.08 -0.17 -0.21 
Δ Body Fat (kg) -0.09 0.11 -0.35 -0.61* -0.58* 
Δ HDL Cholesterol 
(mg/dL) 
-0.30 -0.32 0.02 0.22 0.20 
Δ LDL Cholesterol 
(mg/dL) 
-0.31 -0.18 -0.16 -0.12 -0.08 
Δ Total Cholesterol 
(mg/dL) 
-0.43 -0.29 -0.21 -0.11 -0.11 
Δ Triglycerides (mg/dL) -0.44 -0.33 -0.47 -0.36 -0.49 
Δ Glucose (mg/dL) -0.06 -0.39 0.27 0.28 0.29 
Δ Insulin (uIU/mL) 0.51+ 0.19 0.31 0.22 0.26 
Δ VO2peak  
(mL ∙ kg−1 ∙ min−1) 
0.08 -0.14 0.19 0.46 0.37 
 
High-Intensity Group Δ Step Count Δ Time in 
Light Intensity 
(min) 
Δ Time in 
Moderate 
Intensity (min) 
Δ Time in 
Vigorous Intensity 
(min) 
Δ Time in 
MVPA (min) 
Δ Weight (kgs) 0.24 0.15 0.05 0.18 0.06 
Δ BMI (kg/m2) .23 0.13 0.18 0.18 0.07 
Δ Waist Circumference 
(cm) 
-0.09 0.10 -0.40 -0.27 -0.39 
Δ Body Fat (kg) 0.15 0.05 0.01 0.13 0.02 
Δ HDL Cholesterol 
(mg/dL) 
0.17 0.03 0.26 0.37 0.26 
Δ LDL Cholesterol 
(mg/dL) 
0.22 0.42 -0.23 -0.02 -0.21 
Δ Total Cholesterol 
(mg/dL) 
0.25 0.30 -0.05 0.19 -0.03 
Δ Triglycerides (mg/dL) 0.25 0.01 0.40 0.61* 0.44 
Δ Glucose (mg/dL) 0.58* 0.65* 0.13 0.12 0.15 
Δ Insulin (uIU/mL) -0.14 -0.32 0.11 0.21 0.12 
Δ VO2peak (mL ∙ kg−1 ∙
min−1) 
-0.40 -0.13 -0.45 -0.67* -0.49 
*Significant at p≤0.05 +Approached significance (p≤0.1) 
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Table 4: Tertile Baseline Characteristics 
+(1-2) Significant difference in time in light-intensity and glucose 









 Group 1 (n=12) Group 2 (n=14) Group 3 (n=13) 
Weight (kgs) 94.05 ± 18.37 99.48 ± 14.62 96.17 ±18.37 
BMI (kg/m2) 33.79 ± 5.86 34.85 ± 4.56 34.68 ± 6.94 
Waist Circumference (cm) 96.28 ± 14.38 98.05 ± 10.60 99.30 ± 11.61 
Body Fat (kg) 38.01 ± 12.47 41.80 ± 8.98 41.10 ± 15.13 
HDL Cholesterol (mg/dL) 52.33 ± 10.85 53.36 ± 15.15 52.77 ± 15.35 
LDL Cholesterol (mg/dL) 107.33 ± 30.59 103.50 ± 39.25 115.54 ± 20.19 
Total Cholesterol (mg/dL) 176.58 ± 30.15 174.64 ± 42.34 191.38 ± 21.98 
Triglycerides (mg/dL) 84.75 ± 20.41 88.29 ± 37.81 115.31 ± 53.51 
Glucose (mg/dL) 89.17 ± 8.31+ 97.07 ± 7.93+ 92.38 ± 6.31 
Insulin (uIU/mL) 14.54 ± 8.82 15.23 ± 6.68 16.48 ± 10.45 
VO2peak (mL ∙ kg−1 ∙ min−1) 20.34 ± 5.63 20.35 ± 4.82 19.31 ± 5.85 
Average Step Count 8750.1 ± 2874.6† 6433.7 ± 2533.0 5340.0 ± 2332.0† 
Time in Light Intensity (min) 297.97 ± 58.98+† 231.15 ± 49.39+ 210.32 ± 61.92† 
Time in Moderate Intensity (min) 15.55 ± 15.56 8.12 ± 14.37 7.00 ± 8.69 
Time in Vigorous Intensity (min) 5.16 ± 6.07 3.00 ± 5.13 1.00 ± 1.49 
Time in MVPA (min) 20.38 ± 20.33 11.12 ± 18.79 8.00 ± 10.06 
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Table 5: Tertile Change in Intervention Factors 
 Group 1 Group 2 Group 3 
Δ Weight (kgs) -1.44 ± 3.16** 1.12 ± 3.11 1.41 ± 3.35** 
Δ BMI (kg/m2) -0.49 ± 1.11** 0.46 ± 1.15 0.54 ± 1.25** 
Δ Waist Circumference (cm) -0.81 ± 3.74 1.19 ± 5.25 -1.33 ± 3.47 
Δ Body Fat (kg) -1.37 ± 2.97 0.51 ± 3.12 0.28 ± 2.05 
Δ HDL Cholesterol (mg/dL) -1.25 ± 7.01 -1.14 ± 6.14 -3.00 ± 6.32 
Δ LDL Cholesterol (mg/dL) 4.67 ± 15.22 -4.77 ± 15.31 -6.58 ± 16.44 
Δ Total Cholesterol (mg/dL) 2.17 ± 21.75 -8.07 ± 17.66 -9.00 ± 21.02 
Δ Triglycerides (mg/dL) -6.42 ± 22.63 -10.14 ± 22.64 -3.77 ± 24.50 
Δ Glucose (mg/dL) -0.67 ± 6.53 -4.57 ±7.80 -0.92 ± 8.87 
Δ Insulin (uIU/mL) -4.14 ± 7.12 -3.26 ± 7.05 -0.82 ± 7.49 
Δ VO2peak (mL ∙ kg−1 ∙ min−1) 2.18 ± 3.65 1.13 ± 2.92 0.03 ± 2.64 
Δ Step Count -1906.0 ± 903.2* -504.3 ± 363.8* 1026.8 ± 866.3* 
Δ Time in Light Intensity (min) -56.12 ± 34.38† -25.44 ± 33.10‡ 15.79 ± 35.58†‡ 
Δ Time in Moderate Intensity (min) -7.43 ± 9.39+† 0.06 ± 6.94+ 1.84 ± 4.08† 
Δ Time in Vigorous Intensity (min) -2.00 ± 2.35† -0.56 ± 3.96 2.17 ± 2.70† 
Δ Time in MVPA (min) -8.92 ± 10.92† -0.50 ± 9.72 4.04 ± 6.31† 
*Significant between group change for all groups in Δ steps (p≤0.05) 
 +Significant between group change between Group 1 and Group 2 in Δ time in moderate-
intensity (p≤0.05) 
†Significant between group change between Group 1 and Group 3 in Δ time in light-intensity, Δ 
time in moderate-intensity, Δ time in vigorous-intensity, and Δ time in MVPA (p≤0.05) 
‡Significant between group change between Group 2 and Group 3 in Δ time in light-intensity 
(p≤0.05) 
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